CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
The product is expected to start contributing meaningfully to the revenue from FY25
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
The hospital hosted a two-day event with top internal and external faculty and medical experts
The brand has launched 6 new range of products to provide a complete pregnancy care solution
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
Subscribe To Our Newsletter & Stay Updated
